Varian Medical Systems (VAR) : Ownership Capital B.v. scooped up 82,647 additional shares in Varian Medical Systems during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 632,574 shares of Varian Medical Systems which is valued at $55,982,799.Varian Medical Systems makes up approximately 8.51% of Ownership Capital B.v.’s portfolio.
Other Hedge Funds, Including , Jensen Investment Management Inc reduced its stake in VAR by selling 190 shares or 2.21% in the most recent quarter. The Hedge Fund company now holds 8,403 shares of VAR which is valued at $743,666. Varian Medical Systems makes up approx 0.01% of Jensen Investment Management Inc’s portfolio.Norris Perne French Llpmi reduced its stake in VAR by selling 17,350 shares or 12.02% in the most recent quarter. The Hedge Fund company now holds 127,038 shares of VAR which is valued at $11,242,863. Varian Medical Systems makes up approx 2.35% of Norris Perne French Llpmi’s portfolio.Nordea Investment Management Ab boosted its stake in VAR in the latest quarter, The investment management firm added 438,348 additional shares and now holds a total of 590,879 shares of Varian Medical Systems which is valued at $51,471,470. Varian Medical Systems makes up approx 0.15% of Nordea Investment Management Ab’s portfolio. Eqis Capital Management sold out all of its stake in VAR during the most recent quarter. The investment firm sold 3,227 shares of VAR which is valued $279,071.Cutler Group Lp reduced its stake in VAR by selling 1,522 shares or 91.69% in the most recent quarter. The Hedge Fund company now holds 138 shares of VAR which is valued at $11,922.
Varian Medical Systems opened for trading at $94.09 and hit $95.06 on the upside on Friday, eventually ending the session at $94.74, with a gain of 0.76% or 0.71 points. The heightened volatility saw the trading volume jump to 11,80,328 shares. Company has a market cap of $9,021 M.
On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.
Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Companys products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Companys customers include university research and community hospitals private and governmental institutions healthcare agencies doctors offices and cancer care clinics.